WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

Sehr allgemein und WuXi wird nur kurz erwähnt: https://m.jrj.com.cn/madapter/stock/2021/11/26084433922214.shtml Pharmaceuticals] 2021 three quarterly report summary report: recovery of high growth, medicine enters a long cycle of valuation switching

WuXi Biologics (02269 HK) granted 3,944,600 restricted shares in the award plan to 486 employees https://m.jrj.com.cn/madapter/hk/2021/11/23213333911332.shtml

First GMP Production at 24,000L Line of MFG5 Facility Successfully Completed at WuXi Biologics https://www.prnewswire.com/news-releases/first-gmp-production-at-24-000l-line-of-mfg5-facility-successfully-completed-at-wuxi-biologics-301430423.html MFG5 60,000L capacity is all put in use. Total capacity increased to 150,000L to support late-phase and commercial manufacturing projects.

Für mich persönlich ist Wuxi eigentlich ein Wert, der sich eigentlich nicjt so um die Impfstoffe dreht... Verstehe daher nach wie vor nicht so wirklich, warum Wuxi immer wieder anhand neuer Impfstoffe abgestraft wird 🤷‍♂️

http://www.aastocks.com/tc/stocks/news/aafn-con/rum.211122_152310/latest-news Impfstoff-Aktien fielen WuXi Biologics (02269 HK) und Clover (02197 HK) fielen um 6% und 17%

Institutional investors have a lot riding on WuXi Biologics (Cayman) Inc. (HKG:2269) with 46% ownership https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/institutional-investors-have-a-lot-riding-on-wuxi-biologics

M Stanley Ramps Up HSI End-2022 Target to 25,000; Outlook Cautious http:///en/stocks/news/aafn-con/now.1142993/latest-news Morgan Stanley published the 2022 outlook report on the Chinese equity market, remarking that the relevant risks for MSCI China Index will continue to linger into 2022.    ... ... The broker also released a list of stocks to focus on in the Chinese and Hong Kong markets, which includes  ... WUXI BIO ...

Gerne 👍🍀 Hab einen schönen Sonntag!

Summer, vielen Dank für die ganzen Infos, die du hier postest🙏👍✌️

UBS taps 30 stocks for 2030 in disruptor sectors: Alpha Tactics https:///news/3768851-ubs-taps-30-stocks-for-2030-in-disruptor-sectors UBS highlights its picks in its four next-big-thing sectors: Greentech, 5G+, Fintech and Healthtech. "While this is a longer-term focus, we see attractive investment opportunities in the short to medium term whereby companies benefit from significant fiscal spending following the pandemic as well as new technological innovations," the team of equity and thematic analysts writes in a note. ... WuXi Biologics (OTCPK:WXXWY) The company has "stepped into the high-growth vaccine CDMO business, which has been catalyzed by the breakout of the COVID-19 global pandemic."

CICC: Pharmas Have Deployment Value after Correction; WUXI BIO, INNOVENT BIO Look Good among H Shrs http://www.aastocks.com/en/stocks/news/aafn-con/now.1141378/latest-news

Hong Kong stocks move | WuXi Biologics (02269) rebounded by 7%, leading gains in CXO sector industry boom is still confirmed, new crown drug development is good for CDMO leader https://m.jrj.com.cn/madapter/hk/2021/11/09113733827048.shtml

Sollte sie eigentlich. War ja ein kollektiver Abverkauf nach den Pfizer-News.

Mist, bin jetzt im Minus...bin gespannt ob sie sich wieder erholt.

The CEO & Executive Director of WuXi Biologics (Cayman) Inc. (HKG:2269), Zhisheng Chen, Just Bought 3.3% More Shares https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/the-ceo-executive-director-of-wuxi-biologics-cayman-inc-hkg2 Pfizer Covid Pill Hits Shares of Asian Covid Vaccine Makers https://www.bnnbloomberg.ca/pfizer-covid-pill-hits-shares-of-asian-covid-vaccine-makers-1.1678426 Hong Kong stocks move | WuXi Biologics (02269) plunges 8%, new orders for new crown project may be under pressure https://m.jrj.com.cn/madapter/hk/2021/11/08103133822371.shtml

Zhongtai International: Heraufstufung des Kursziels von WuXi Biologics (02269) auf HK$143,7, Rating-Upgrade auf "Kaufen" https://m.jrj.com.cn/madapter/hk/2021/11/05135033816709.shtml